Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment (CT05)

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by (Responsible Party):

Chiesi Pharmaceuticals Inc.

ClinicalTrials.gov Identifier:

NCT01723670

First received: October 31, 2012

Last updated: November 20, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	March 2016
Estimated Primary Completion Date:	March 2016 (Final data collection date for primary outcome measure)